Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI)
Completed · Phase 2
Conditions studied: Coronary Artery Disease, Coronary Disease, Myocardial Ischemia, Heart Diseases, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Vascular Diseases
In brief
The objective of this study is to evaluate the safety and effectiveness of the clinical and technical performance of the CorPath® 200 System in the delivery and manipulation of coronary guidewires and stent/balloon systems for use in percutaneous coronary interventions (PCI).
Key facts
- Study ID
- NCT01275092
- Run by
- Siemens Healthineers Endovascular Robotics, Inc.
- People needed
- 164
- Starts
- 2011-01-01
- Expected to finish
- 2012-01-01
- Last updated by the study team
- 2013-08-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Washington Hospital Center — Washington D.C., District of Columbia, United States
- Northeast Georgia Heart Center — Gainesville, Georgia, United States
- St. Elizabeth's Medical Center — Boston, Massachusetts, United States
- Columbia University Medical Center — New York, New York, United States
- Saint Joseph's Hospital — Syracuse, New York, United States
- Wellmont CVA Heart Institute — Kingsport, Tennessee, United States
- Virginia Commonwealth University — Richmond, Virginia, United States
- Swedish Medical Center — Seattle, Washington, United States
- CORBIC — Medellín, Colombia
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.